Skip to main content
Erschienen in: American Journal of Clinical Dermatology 2/2015

01.04.2015 | Original Research Article

Clinicopathological and Diagnostic Characterization of Confluent and Reticulate Papillomatosis of Gougerot and Carteaud: A Retrospective Study in a South-East Asian Population

verfasst von: Wenhui Huang, Gavin Ong, Wei-Sheng Chong

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Confluent and reticulate papillomatosis of Gougerot and Carteaud (CRP) is a rare dermatological condition, which has not been reported widely in Asian populations.

Aim

To characterize the clinicopathological and diagnostic features of CRP in a South-East Asian population.

Methods

The medical records of 29 patients accorded the diagnosis of CRP at the National Skin Centre, Singapore, from 1990 to 2011, were analyzed.

Results

The male to female ratio was 2.6:1. Eight patients were Indians. The mean age at the onset of skin eruptions was 29.1 years (range 16–55 years), while the mean duration was 19.9 months (range 0.5–120 months). CRP itself was the most common preliminary diagnosis. Fungal smears were negative in all 22 instances. All 29 patients had received a trial of antifungal therapy before being seen at our center. Antifungal therapy was repeated in three subjects, and the response was uniformly poor. Conversely, the treatment response with tetracyclines was excellent, yielding more than a 50 % response in all 14 patients. Four patients suffered recurrence of CRP. According to the diagnostic criteria set forth by Davis et al., 25/29 patients (86.2 %) and 19/29 patients (65.6 %) fulfilled at least three and four criteria, respectively.

Conclusion

A predilection for male gender and Indian ethnicity were noted in our study. The diagnosis of CRP was often made clinically, and investigations were mainly ancillary. The treatment response was poor with antifungal agents but excellent with tetracyclines. The diagnostic criteria proposed by Davis et al. were found to be useful in our cohort of patients.
Literatur
1.
Zurück zum Zitat Yesudian P, Kamalam S, Razack A. Confluent and reticulated papillomatosis (Gougerot–Carteaud): an abnormal host reaction to Malassezzia furfur. Acta Derm Venereol (Stockh). 1973;53:381–4. Yesudian P, Kamalam S, Razack A. Confluent and reticulated papillomatosis (Gougerot–Carteaud): an abnormal host reaction to Malassezzia furfur. Acta Derm Venereol (Stockh). 1973;53:381–4.
2.
Zurück zum Zitat Pedrosa AF, Lisboa C, Goncalves Rodrigues A. Malassezia infections: a medical conundrum. J Am Acad Dermatol. 2014;71:170–6.CrossRefPubMed Pedrosa AF, Lisboa C, Goncalves Rodrigues A. Malassezia infections: a medical conundrum. J Am Acad Dermatol. 2014;71:170–6.CrossRefPubMed
3.
Zurück zum Zitat Davis MD, Weenig RH, Camilleri MJ. Confluent and reticulate papillomatosis (Gougerot–Carteaud syndrome): a minocycline-responsive dermatosis without evidence for yeast in pathogenesis. A study of 39 patients and a proposal of diagnostic criteria. Br J Dermatol. 2006;154:287–93.CrossRefPubMed Davis MD, Weenig RH, Camilleri MJ. Confluent and reticulate papillomatosis (Gougerot–Carteaud syndrome): a minocycline-responsive dermatosis without evidence for yeast in pathogenesis. A study of 39 patients and a proposal of diagnostic criteria. Br J Dermatol. 2006;154:287–93.CrossRefPubMed
4.
Zurück zum Zitat Bernardes Filho F, Quaresma MV, Rezende FC, Kac BK, Nery JA, Azulay-Abulafia L. Confluent and reticulate papillomatosis of Gougerot–Carteaud and obesity: dermoscopic findings. An Bras Dermatol. 2014;89:507–9.CrossRefPubMed Bernardes Filho F, Quaresma MV, Rezende FC, Kac BK, Nery JA, Azulay-Abulafia L. Confluent and reticulate papillomatosis of Gougerot–Carteaud and obesity: dermoscopic findings. An Bras Dermatol. 2014;89:507–9.CrossRefPubMed
5.
Zurück zum Zitat Tamraz H, Raffoul M, Kurban M, Kibbi AG, Abbas O. Confluent and reticulated papillomatosis: clinical and histopathological study of 10 cases from Lebanon. J Eur Acad Dermatol Venereol. 2013;27:e119–23.CrossRefPubMed Tamraz H, Raffoul M, Kurban M, Kibbi AG, Abbas O. Confluent and reticulated papillomatosis: clinical and histopathological study of 10 cases from Lebanon. J Eur Acad Dermatol Venereol. 2013;27:e119–23.CrossRefPubMed
7.
Zurück zum Zitat Kim JS, Paek JO, Kang HS, Yu HJ. Familial confluent and reticulate papillomatosis successfully treated with minocycline. Cutis. 2014;4:199–203. Kim JS, Paek JO, Kang HS, Yu HJ. Familial confluent and reticulate papillomatosis successfully treated with minocycline. Cutis. 2014;4:199–203.
8.
Zurück zum Zitat Eisman S, Rustin MH. Recurrent confluent and reticulate papillomatosis of Gougerot and Carteaud in siblings. Clin Exp Dermatol. 2003;28:325–6.CrossRefPubMed Eisman S, Rustin MH. Recurrent confluent and reticulate papillomatosis of Gougerot and Carteaud in siblings. Clin Exp Dermatol. 2003;28:325–6.CrossRefPubMed
9.
Zurück zum Zitat Dogan G. Pruritic eruption with reticular pigmentation: confluent and reticulate papillomatosis. Australas J Dermatol. 2007;48:185–6.CrossRefPubMed Dogan G. Pruritic eruption with reticular pigmentation: confluent and reticulate papillomatosis. Australas J Dermatol. 2007;48:185–6.CrossRefPubMed
10.
Zurück zum Zitat Davis RF, Harman KE. Confluent and reticulated papillomatosis successfully treated with amoxicillin. Br J Dermatol. 2007;156:583–4.CrossRefPubMed Davis RF, Harman KE. Confluent and reticulated papillomatosis successfully treated with amoxicillin. Br J Dermatol. 2007;156:583–4.CrossRefPubMed
11.
Zurück zum Zitat Natarajan S, Milne D, Jones AL, Goodfellow M, Perry J, Koerner RJ. Dietzia strain X: a newly described actinomycete isolated from confluent and reticulate papillomatosis. Br J Dermatol. 2005;153:825–7.CrossRefPubMed Natarajan S, Milne D, Jones AL, Goodfellow M, Perry J, Koerner RJ. Dietzia strain X: a newly described actinomycete isolated from confluent and reticulate papillomatosis. Br J Dermatol. 2005;153:825–7.CrossRefPubMed
12.
Zurück zum Zitat Jones AL, Koerner RJ, Natarajan S, Perry JD, Goodfellow M. Dietziapapillomatosis sp. nov., a novel actinomycete isolated from the skin of an immunocompetent patient with confluent and reticulated papillomatosis. Int J Syst Evol Microbiol. 2008;58:68–72.CrossRefPubMed Jones AL, Koerner RJ, Natarajan S, Perry JD, Goodfellow M. Dietziapapillomatosis sp. nov., a novel actinomycete isolated from the skin of an immunocompetent patient with confluent and reticulated papillomatosis. Int J Syst Evol Microbiol. 2008;58:68–72.CrossRefPubMed
Metadaten
Titel
Clinicopathological and Diagnostic Characterization of Confluent and Reticulate Papillomatosis of Gougerot and Carteaud: A Retrospective Study in a South-East Asian Population
verfasst von
Wenhui Huang
Gavin Ong
Wei-Sheng Chong
Publikationsdatum
01.04.2015
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 2/2015
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-014-0110-8

Weitere Artikel der Ausgabe 2/2015

American Journal of Clinical Dermatology 2/2015 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders scheint das auf weibliche Kranke zuzutreffen, wie eine Studie zeigt.

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.